Crown Laboratories Acquires Xycrobe Therapeutics, Inc.
May 22, 2019
Crown Laboratories, a privately held skin care company based in Johnson City, Tennessee, has acquired Xycrobe Therapeutics, a developer of skin microbiome-based biotherapeutic technology. Crown plans to integrate Xycrobe’s microbiome platform and scientific team into its R&D organization to expand therapeutic and consumer skin-care capabilities; financial terms were not disclosed.
- Buyers
- Crown Laboratories, Inc.
- Targets
- Xycrobe Therapeutics, Inc.
- Industry
- Biotechnology
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Crown Laboratories Acquires Keri Brand from GlaxoSmithKline
May 1, 2019
Consumer Products
Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.
-
Crown Laboratories Acquires Revance Therapeutics
August 12, 2024
Biotechnology
Crown Laboratories, a Hildred Capital portfolio company, completed the acquisition of Revance Therapeutics through a cash tender offer that expired February 4, 2025; the transaction closed on February 6, 2025 and Revance will be delisted from Nasdaq. The deal brings together Crown's skincare and consumer brands with Revance's DAXXIFY, RHA dermal fillers and other aesthetics/therapeutic offerings to expand product portfolio and commercialization capabilities across medical, retail and e-commerce channels.
-
Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets
May 24, 2022
Medical Devices
Crown Laboratories has acquired the global, aesthetics-focused assets of Eclipse Medcorp, LLC, expanding Crown's aesthetics product portfolio and integrating Eclipse's devices into its Aesthetics business unit. The deal aims to broaden Crown's product offerings to aesthetics providers domestically and internationally and preserve service and medical-education support for Eclipse customers under Crown.
-
Mapmygenome Acquires Microbiome Insights
May 29, 2025
Biotechnology
Mapmygenome, an AI-driven genomics company based in Hyderabad, India, has acquired Microbiome Insights, a Canadian microbiome sequencing and bioinformatics CRO with a CAP-accredited lab. The deal expands Mapmygenome's capabilities in metagenomics and bioinformatics and accelerates its geographic expansion into North America; financial terms were not disclosed.
-
Crown Laboratories Acquires StriVectin from L Catterton
August 26, 2021
Consumer Products
Crown Laboratories, a Hildred Capital portfolio company, has entered into a definitive agreement to acquire StriVectin from L Catterton. StriVectin will operate as a wholly owned subsidiary within Crown's new Premium Skincare Division, with its president Cori Aleardi joining Crown's executive team; the deal was expected to close by mid-September 2021.
-
PanTheryx Acquires TruBiotics Brand from Bayer HealthCare LLC
March 1, 2021
Food & Beverage
PanTheryx, a Phoenix-based nutrition and biotechnology company, acquired the TruBiotics probiotic supplement brand and related trademarks from Bayer HealthCare LLC. The acquisition adds a recognized probiotics brand to PanTheryx’s portfolio to expand its digestive and immune health product lines and to accelerate growth through existing retail and e‑commerce channels.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.